Evidence for Interindividual Heterogeneity in the Glucose Gradient Across the Human Red Blood Cell Membrane and Its Relationship to Hemoglobin Glycation
2008/07/01 by Paramjit K. Khera, Clinton H. Joiner, Anthony Carruthers +5 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Glycation End Products research #Blood properties and coagulation #Erythrocyte Function and Pathophysiology
paper · pdf · doi:10.2337/db07-1820
Abstract
OBJECTIVE: To determine whether interindividual heterogeneity in the erythrocyte (red blood cell [RBC]) transmembrane glucose gradient might explain discordances between A1C and glycemic control based on measured fructosamine. RESEARCH DESIGN AND METHODS: We modeled the relationship between plasma glucose and RBC glucose as the concentration distribution (C(i)-to-C(o) ratio) of a nonmetabolizable glucose analog (14)C-3-O-methyl glucose ((14)C-3OMG) inside (C(i)) and outside (C(o)) RBCs in vitro. We examined the relationship between that distribution and the degree of glycation of hemoglobin in comparison with glycation of serum proteins (fructosamine), the glycation gap. A1C, fructosamine, and in vitro determination of the (14)C-3OMG distribution in glucose-depleted RBCs were measured in 26 fasted subjects. RESULTS: The C(i)-to-C(o) ratio 0.89 +/- 0.07 for 3-O-methyl-d-glucopyranose (3OMG) ranged widely (0.72-1.04, n = 26). In contrast, urea C(i)-to-C(o) (1.015 +/- 0.022 [range 0.98-1.07], P < 0.0001) did not. Concerning mechanism, in a representative subset of subjects, the C(i)-to-C(o) ratio was retained in RBC ghosts, was not dependent on ATP or external cations, and was reestablished after reversal of the glucose gradient. The 3OMG C(i)-to-C(o) ratio was not correlated with serum fructosamine, suggesting that it was independent of mean plasma glucose. However, C(i)-to-C(o) did correlate with A1C (R(2) = 0.19) and with the glycation gap (R(2) = 0.20), consistent with a model in which differences in internal glucose concentration at a given mean plasma glucose contribute to differences in A1C for given level of glycemic control. CONCLUSIONS: The data demonstrate interindividual heterogeneity in glucose gradients across RBC membranes that may affect hemoglobin glycation and have implications for diabetes complications risk and risk assessment.
Cited by
- Sex differences between mid-life glycaemic traits and brain volume at age 70: a population-based study
- A1C: recommendations, debates, and questions. [europepmc]
- Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. [europepmc]
- Effects of flaxseed oil on anti-oxidative system and membrane deformation of human peripheral blood erythrocytes in high glucose level. [europepmc]
- Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis. [europepmc]
- Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. [europepmc]
- Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels. [europepmc]
- Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation. [europepmc]
- Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome. [europepmc]
- Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress. [europepmc]
- Differences in Red Blood Cell Indices Do Not Explain Racial Disparity in Hemoglobin A1c in Children with Type 1 Diabetes. [europepmc]
- DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes. [europepmc]
- Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis. [europepmc]
- Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters. [europepmc]
- Distribution of glycated haemoglobin and its determinants in Korean youth and young adults: a nationwide population-based study. [europepmc]
- Update on biomarkers of glycemic control. [europepmc]
- A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management. [europepmc]
- Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes. [europepmc]
- The trials and tribulations of determining HbA 1c targets for diabetes mellitus. [europepmc]
- Biomedical Properties of Propolis on Diverse Chronic Diseases and Its Potential Applications and Health Benefits. [europepmc]
- Addressing shortfalls of laboratory HbA 1c using a model that incorporates red cell lifespan. [europepmc]
- Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. [europepmc]
- Analytical Challenges in Diabetes Management: Towards Glycated Albumin Point-of-Care Detection. [europepmc]
- Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study. [europepmc]
- Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-A study based on the MIMIC-IV database. [europepmc]
- Hemoglobin glycation index and cardiovascular outcomes in patients with diabetes and coronary artery disease: insights from a large cohort study. [europepmc]
Related